Brief: China Nt Pharma Announces Memorandum Of Understanding On Possible Cooperation
09/10/2023 15:33
Oct 9 (Reuters) - China NT Pharma Group Company Ltd
1011.HK :
* MEMORANDUM OF UNDERSTANDING ON POSSIBLE COOPERATION
* UNDER MOU, CO & GLOBAL NEW NORMAL FUND ARE WILLING TO HAVE
POSSIBLE COOPERATION ON GROUP'S BUSINESS IN FIELD OF ORTHOPEDICS
* CO AND GLOBAL NEW NORMAL ANTI-INFLATION LIMITED
PARTNERSHIP FUND
ENTERED INTO A NON-LEGALLY BINDING MOU
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY